Both in Biotechnology
Agenus vs Eikon Therapeutics
Over the past year AGEN returned +151.6% and EIKN returned −57.4%; their daily moves had a correlation of 0.26.
AGEN +151.6% EIKN −57.4%Growth of $1, one year, split-adjusted
| Metric | AGEN | EIKN |
|---|---|---|
| Price | $6.97 | $6.39 |
| Market cap | $314.8M | $346.1M |
| Today | +4.50% | +15.14% |
| 1 month | −6.9% | −14.9% |
| 6 months | +79.2% | −35.9% |
| Year to date | +122.0% | — |
| 1 year | +75.6% | — |
| Revenue growth (YoY) | +34.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1.7% | — |
| P/E (TTM) | 3.4× | — |
| Price / sales | 2.4× | — |
| Net cash | -$11.3M | $531.2M |
| Dividend yield | — | — |
| Volatility (60d) | 88.9% | 103.8% |
| Short % of float | 16.6% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).